Previous Blogs

Extractables and Leachables Testing

By Amy Miller

March 17, 2022

The FDA states: Drug product containers and closures shall not be reactive, additive, or absorptive so as to alter the safety, identity, strength, quality or purity of the drug beyond the official or established requirements.*  While they make this statement, there is no prescription offered in actually how to execute an extractables and leachables evaluation, which is, of course, an essential aspect of demonstrating suitability of containers and closures.

AccelTRA Stoppers

By Prabhaharan Sankaran

June 02, 2021

For any drug, selection of the appropriate primary packaging components is essential to having a containment system that ensures quality, safety, and stability. The primary packaging components are selected based on various factors, which include chemical compatibility with the drug product ingredients and dimensional fit with mating packaging components. Optimized fit among mating packaging components is essential for flawless fill-finish processing.

AccelTRA RTS/RTU Components

By Darshana Chavan

March 05, 2021

To meet the ever-increasing demand of growing domestic pharmaceutical markets, the AccelTRA® Components Program has expanded to include an RTS/RTU product line with Ready-to-Sterilize (RTS) and Ready-to-Use (RTU) gamma sterilized stoppers developed to provide an innovative customer service package to help customers get their products to market quickly.

By Your Side for Innovation

By Chris Ryan

November 13, 2019

When faced with drug shortages or supply chain issues affecting a branded drug product, generic drug manufacturers need to move quickly to help ensure that needed therapies reach the market safely and efficiently. Access to high-quality packaging and delivery components can make a huge difference in ensuring patients receive life-saving medications on schedule.